In patients with hypertrophic cardiomyopathy myocardial fibrosis is associated with both left ventricular and left

Christian Prinz1, Frank Van Buuren, Nicola Bogunovic

  • 1Dept. of Cardiology, Heart and Diabetes Centre North-Rhine Westphalia, Ruhr University Bochum, Bad Oeynhausen, Germany. Cchrprinz@aol.com

Acta Cardiologica
|May 31, 2012
PubMed

Insights

Myocardial fibrosis in hypertrophic cardiomyopathy is linked to impaired left atrial and ventricular function. This dysfunction correlates with more severe heart failure symptoms, highlighting fibrosis as a key indicator of disease progression.

Area of Science:

  • Cardiology
  • Cardiovascular Imaging
  • Cardiac Physiology

Background:

  • Hypertrophic cardiomyopathy (HCM) is a genetic heart muscle disease characterized by left ventricular hypertrophy.
  • Myocardial fibrosis, the deposition of collagen in the heart muscle, is a common finding in HCM and is associated with adverse outcomes.
  • Left atrial (LA) function plays a crucial role in diastolic filling and overall cardiac performance.

Purpose of the Study:

  • To evaluate left atrial (LA) function using two-dimensional speckle-tracking echocardiography (2DSTE).
  • To investigate the relationship between LA function and myocardial fibrosis in patients with hypertrophic cardiomyopathy (HCM).

Main Methods:

  • 30 HCM patients underwent 2DSTE to assess global longitudinal left ventricular (LV) strain and LA strain/strain-rate parameters.
  • Delayed-enhancement magnetic resonance imaging (DE-MRI) was used to detect and quantify myocardial fibrosis.
  • Patients were categorized into two groups: no fibrosis and moderate-to-severe fibrosis in at least two LV segments.

Main Results:

  • 20 patients (66.7%) exhibited moderate or severe myocardial fibrosis.
  • Patients with fibrosis showed significantly reduced global longitudinal LV strain and peak LA strain compared to those without fibrosis.
  • Increased indexed LA volume and higher New York Heart Association (NYHA) class were observed in patients with significant fibrosis, correlating with impaired LA and LV function.

Conclusions:

  • Myocardial fibrosis in HCM is associated with impaired left atrial and left ventricular function.
  • The presence and extent of fibrosis correlate with the severity of heart failure symptoms (NYHA class).
  • 2DSTE is a valuable tool for assessing LA dysfunction in the context of HCM-related myocardial fibrosis.
Abstract

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...